RhoGDIα suppresses growth and survival of prostate cancer cells

BACKGROUND: Treatment for primary prostate cancer (CaP) is the withdrawal of androgens. However, CaP eventually progresses to grow in a castration-resistant state. The mechanisms involved in the development and progression of castration-resistant prostate cancer (CRPC) remain unknown. We have previo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Zhu, Yezi, Tummala, Ramakumar, Liu, Chengfei, Nadiminty, Nagalakshmi, Lou, Wei, Evans, Christopher P., Zhou, Qinghua, Gao, Allen C.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961824/
https://ncbi.nlm.nih.gov/pubmed/21681778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21441
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki